Genes2Me unveils CoviEasy self-test kit with 98% accuracy for COVID-19
Category: #business  | By Nikita Chaurasia  | Date: 2022-06-14 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Genes2Me unveils CoviEasy self-test kit with 98% accuracy for COVID-19

Genes2Me has recently announced the successful launch of a self-test rapid antigen test kit, CoviEasy for COVID-19, that provides faster results in 10 minutes.

Supported by AI-determined Mobile App, the IVD product offers concordance of nearly 98% accuracy and sensitivity.

CoviEasy has undergone several quality checks at the ICMR appropriate validation centre and received acceptance from CDSCO India.

As per credible sources, the CoviEasy test can be undertaken by following the simple instructions provided on the Mobile App (available on both iOS and Android platforms), resulting in automated reporting of test results from the mobile app itself.

The cost of the kit is said to be just $3.19.

The CoviEasy test includes a couple of steps as it is conducted with a nasal swab sampling, where the swab is injected into the nostrils. The swab must be immersed in the tube and swirled about eight to ten times in the extraction buffer. The buffer is then released onto the test equipment, showing the test results as negative or positive.

The test device is embedded with a QR code for patient data entry and report generation.

While commenting on the product launch, Neeraj Gupta, Genes2Me Founder and CEO, said that as now many people are opting to get the test done at home to detect whether they are positive or not, accuracy becomes the most critical and non-negotiable factor.

Neeraj added that the firm understood this need of the hour and devised a test kit which is more than 98 per cent accurate and effective.

The CoviEasy kit will be offering almost the results and effectiveness of RTPCR with the practicality of an at home self-test kit. The firm plans to aid society with the most accurate equipment in India and suffice the need with the advanced manufacturing unit.

Source Credit - https://www.expresshealthcare.in/news/genes2me-launches-covieasy-self-test-kit-for-covid-19/435370/

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Tata Elxsi Shares Rise 2% as ISRO Partnership Fuels Investor Optimism

Tata Elxsi Shares Rise 2% as ISRO Partnership Fuels Investor Optimism

By Nikita Chaurasia

In recent turn of events, Tata Elxsi reportedly experienced a positive surge of over 2% in its shares on Thursday as investors welcomed the company's collaboration with the Indian Space Research Organization (ISRO) for the upcoming Gaganyaan Miss...

General Motors passes Ford to become the second-best EV seller in U.S.

General Motors passes Ford to become the second-best EV seller in U.S.

By Nikita Chaurasia

Detroit-based American multinational automaker, General Motors, has reportedly pulled ahead of fellow American rival, Ford Motor, to establish itself as second-biggest seller of all-electric vehicles in the US during the first quarter of 2023. The...

McKinsey commences job cuts focused on non-client serving teams

McKinsey commences job cuts focused on non-client serving teams

By Nikita Chaurasia

McKinsey and Co. a consulting giant entity has decided to start cutting jobs in one of the biggest rounds of layoffs for the company. This is likely to eliminate the jobs of about 2000 employees from work. The layoffs will be focused on support st...